SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-24-002118
Filing Date
2024-03-04
Accepted
2024-03-04 17:37:18
Documents
2
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1733
2 POA RIBEIRO ribeiro_poa2023.txt EX-24 3027
  Complete submission text file 0001562180-24-002118.txt   6473
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET, SUITE A-210 WATERTOWN MA 02472
Business Address
Ribeiro Ramiro (Reporting) CIK: 0002013623 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 24716521